Epidemiological Study to Assess the Symptoms and Patterns of Diagnosis and Treatment of GERD

This study has been completed.
Sponsor:
Information provided by:
AstraZeneca
ClinicalTrials.gov Identifier:
NCT00524355
First received: August 30, 2007
Last updated: July 16, 2009
Last verified: July 2009
  Purpose

To describe the frequency, type and severity of the symptoms in patients visiting the GI or internal physicians, with symptoms consistent with gastroesophageal reflux disease (GERD)


Condition
GERD

Study Type: Observational
Study Design: Time Perspective: Prospective
Official Title: Epidemiological Study to Assess the Symptoms and Patterns of Diagnosis and Treatment of the Gastroesophageal Reflux Disease

Resource links provided by NLM:


Further study details as provided by AstraZeneca:

Enrollment: 2717
Study Start Date: March 2007
Study Completion Date: November 2007
  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population

primary care clinics, private clinics and out-patient department at hospitals in cities and provinces of Viet Nam

Criteria

Inclusion Criteria:

  • Patients from both sexes, aged 18 years or older
  • Patients complaining of symptoms consistent with reflux disease

Exclusion Criteria:

  • Patients with GI cancer and those where the only reason for the visit is renewing the prescription are excluded
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00524355

Locations
Vietnam
Research Site
Hanoi, Vietnam
Research Site
Ho Chi Minh City, Vietnam
Sponsors and Collaborators
AstraZeneca
Investigators
Study Chair: Ta Long, MD, PhD 108 Hospital, Hanoi
Study Chair: Do Van Dung, MD, PhD Ho Chi Minh City Univ of Medicine and Pharmacist
Principal Investigator: Dao Van Long, MD, PhD Ha Noi University of Medicine Hospital
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00524355     History of Changes
Other Study ID Numbers: NIS-GVN-NEX-2007/1, NIS-G84-GER-2007/2
Study First Received: August 30, 2007
Last Updated: July 16, 2009
Health Authority: Vietnam: Ho Chi Minh City Health Service

Keywords provided by AstraZeneca:
GERD
GIS
heartburn
NIS
PPI

Additional relevant MeSH terms:
Gastroesophageal Reflux
Esophageal Motility Disorders
Deglutition Disorders
Esophageal Diseases
Gastrointestinal Diseases
Digestive System Diseases

ClinicalTrials.gov processed this record on October 19, 2014